Researchers at Moffitt Cancer Center have developed a new tool to predict how cancer cells evolve. By focusing on chromosome ...

Whether for drug screening or toxicity testing, stem cell-based 3D tissue models are key to biomedical research. However, ...

Data integrity is key to the success of any cell therapy program. CDMOs can implement robust data management systems for ...

Inspired by electric rays that generate high voltages through stacked electrocytes, researchers at UNIST have developed a ...

During pregnancy, maternal and fetal cells migrate back and forth across the placenta, with fetal cells entering the mother's ...

Aging comes with graying hair, which may be a sign of the body lowering its risk of cancer, a study suggests. When you purchase through links on our site, we may earn an affiliate commission. Here’s ...

While presenting this year’s Nobel Prize in Physiology or Medicine to three immunologists who discovered and characterized regulatory T cells, committee chair Olle Kämpe, M.D., Ph.D., told the ...

Please provide your email address to receive an email when new articles are posted on . Allogeneic cell therapies help overcome challenges of autologous products, such as manufacturing complexity and ...

CAR T-cell therapy shows promise for SCLC, but significant barriers, such as tumor heterogeneity and immunosuppression, must be addressed. Identifying tumor-selective antigens like CDH17, GD2, and ...

CD19 chimeric antigen receptor (CAR) T-cell therapy showed potential in treating patients with refractory systemic lupus erythematosus (SLE), with B-cell depletion and disease activity reduction ...

Autologous TIL therapy showed potential in stabilizing recurrent/metastatic HNSCC, with an 11% objective response rate and 76% disease control rate. The study highlighted the feasibility of generating ...